Cost-effective routine pharmaceutical testing using radial flow stream splitting HPLC columns: Quantitative analysis and performance metrics in the analysis of over-the-counter drugs

Key findings from this study

• The study found that RFS mode operation reduced backpressure by 30 percent and improved separation efficiency by 120 percent compared with conventional column mode.
• The authors report that analysis time decreased by up to 40 percent in RFS mode while maintaining identical quantitative accuracy and repeatability.
• The researchers demonstrate that over-the-counter drug assays showed no difference in quantitative reliability between RFS and conventional operational modes.

Overview

Radial Flow Stream Splitting (RFS) column technology enables high-resolution pharmaceutical separations at reduced backpressure and increased flow rates. This study evaluated RFS performance against conventional operation using over-the-counter drug assays. The column maintained quantitative accuracy while improving separation efficiency and reducing analysis time.

Methods and approach

Researchers evaluated a novel RFS column technology in pharmaceutical testing applications. Over-the-counter medications served as model analytes for comparative analysis. Performance metrics included separation efficiency, backpressure, analysis time, quantitative accuracy, and assay repeatability between RFS and conventional operational modes.

Results

RFS mode achieved 120 percent improvement in separation efficiency and 30 percent reduction in backpressure relative to conventional column operation. Analysis time decreased by up to 40 percent in RFS mode. Quantitative accuracy and repeatability remained equivalent between RFS and conventional modes across over-the-counter drug assays, indicating no loss of analytical reliability despite accelerated separation conditions.

Implications

RFS column technology addresses fundamental pressure limitations that constrain analytical throughput in routine pharmaceutical testing. The simultaneous achievement of improved separation efficiency, reduced backpressure, and faster analysis times suggests potential for broader application in impurity profiling and degradation product analysis. Cost-effectiveness improves through reduced analysis time without compromising quantitative reliability.

This advancement may facilitate integration of accelerated analytical workflows into quality control operations. The maintenance of assay accuracy at higher flow rates enables pharmaceutical laboratories to balance analytical demand with resource constraints. RFS technology represents a practical solution to pressure-related limitations without requiring method revalidation or equipment upgrades beyond column replacement.

Scope and limitations

This summary is based on the study abstract and available metadata. It does not include a full analysis of the complete paper, supplementary materials, or underlying datasets unless explicitly stated. Findings should be interpreted in the context of the original publication.